In spite of the wide range of individual values of VEGF-A or VEGF-C, median expression of VEGF-C mRNA in PBMCs of the control group were increased by about 43-fold compared to AML patients (p<0.001) (Figure 1). The gene discussed is VEGFC; the disease is acute myeloid leukemia.